Tanya Ravingerova, Adriana Adameova, Lubomir Lonek, Veronika Farkasova, Miroslav Ferko, Natalia Andelova, Branislav Kura, Jan Slezak, Eleftheria Galatou, Antigone Lazou, Vladislava Zohdi, Naranjan S Dhalla
Cardiovascular diseases, especially ischemic heart disease, as a leading cause of heart failure (HF) and mortality, will not reduce over the coming decades despite the progress in pharmacotherapy, interventional cardiology, and surgery. Although patients surviving acute myocardial infarction live longer, alteration of heart function will later lead to HF. Its rising incidence represents a danger, especially among the elderly, with data showing more unfavorable results among females than among males. Experiments revealed an infarct-sparing effect of ischemic "preconditioning" (IPC) as the most robust form of innate cardioprotection based on the heart's adaptation to moderate stress, increasing its resistance to severe insults...
November 18, 2023: International Journal of Molecular Sciences